Congeners derived from microtubule-active phenylpyrimidines produce a potent and long-lasting paralysis in Schistosoma mansoni in vitro

Monti L, Cornec A-S, Oukoloff K, Kovalevich J, Prijs K, Alle A, Brunden KR, Smith AB III, El-Sakkary N, Liu LJ, Syed A, Skinner DE, Ballatore C and Caffarey CR, ACS Infectious Dis. 7(): 1089, 2021

Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice

Delizannis AT, Nonneman A, Tsering W, De Bondt A, Van den Wyngaert I, Zhang B, Meymand E, Olufemi MF, Koivula P, Maimaiti S, Trojanowski JQ, Lee VM and Brunden KR, Acta Neuropathol. Comm. 9(): 150, 2021

In vitro amplification of pathogenic tau conserved disease-specific bioactive characteristics

Xu H, O’Reilly M, Gibbons GS, Changolkar L, McBride JD, Riddle DM, Zhang B, Stieber A, Nirschl J, Kim S-J, Hoxha, K-H, Brunden KR, Schellenberg GD, Trojanowski JQ and Lee YM-Y, Acta Neuropathol. 141(): 193, 2021

Evaluation of structure-activity relationship of microtubule (MT)-targeting 1,2,4-Triazolo[1,5-a]pyrimidines identifies new candidates for neurodegenerative tauopathies

Oukoloff K, Nzou G, Varricchio C, Lucero B, Alle T, Kovalevich J, Monti L, Cornec A-S, Yao Y, James MJ, Trojanowski JQ, Lee VM-Y, Smith AB III, Brancale A, Brunden KR* and Ballatore C, J. Med. Chem. 64(): 1073, 2021

Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease

MX Henderson, DJ Covell, C Hiu-Yan Chung, RM Pitkin, RM Sandler, SC Decker, DM Riddle, B Zhang, RJ Gathagan, MJ James, JQ Trojanowski, KR Brunden, VMY Lee, KC Luk, Neurobiology of Disease 136(): , 2020

Characterization of tau binding by gosuranemab

Sopko R, Golonzhka O, Arndt J, Quan C, Czerkowicz J, Cameron A, Smith B, Murugesan Y, Gibbons G, Kim S-J, Brunden KR, Weinreb PH, Graham DL, and Hering H, Neurobiol. Dis. 146(): 105120, 2020

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease

Gibbons G, Kim S-J, Wu Q, Riddle DM, Leight SN, Changolkar L, Xu H, Meymand ES, O’Reilly M, Zhang B, Brunden KR, Trojanowski JQ and Lee VM-Y, Mol. Neurodegeneratin 15(): 64, 2020

Correction of microtubule defects within Aβ plaque-associated dystrophic axons results in lowered Aβ release and plaque deposition

Y Yao, G Nzou, T Alle, W Tsering, S Maimaiti, JQ Trojanowski, VM-Y Lee, C Ballatore and KR Brunden, Alzheimer's & Dementia, 2020

Compound screening in cell-based models of tau inclusion formation: Comparison of primary neuron and HEK293 cell assays

A Crowe, MJ Henderson, J Anderson, SA Titus, A Zakharov , A Simeonov, A Buist, C Delay, D Moechars, JQ Trojanowski, VM-Y Lee, KR Brunden, Journal of Biological Chemistry, 2020

Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.

He Zhuohao, Guo Jing L, McBride Jennifer D, Narasimhan Sneha, Kim Hyesung, Changolkar Lakshmi, Zhang Bin, Gathagan Ronald J, Yue Cuiyong, Dengler Christopher, Stieber Anna, Nitla Magdalena, Coulter Douglas A, Abel Ted, Brunden Kurt R, Trojanowski John Q, Lee Virginia M-Y, Nature medicine 24(1): 29-38, 2018, PMID:29200205

Read article